TrialStroke2017

Pharmacogenetic Associations of β1-Adrenergic Receptor Polymorphisms With Cardiovascular Outcomes in the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes).

Oyunbileg Magvanjav et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.